Evaluation of a Specialised Tracheostomy Team for the Management of Patients With a Tracheostomy Cannula in a Belgium General Hospital: A Retrospective Study.
Management of Patients With a Tracheostomy Cannula by a Specialised Team in a Belgium General Hospital: A Retrospective Study
Patients admitted to intensive care units (ICUs) frequently require prolonged mechanical ventilation. Difficulties in weaning from mechanical ventilation represent an important indication for performing a tracheotomy, which involves creating a temporary opening in the trachea into which a cannula is inserted. This procedure is often confused with a tracheostomy, in which a permanent stoma is created.
Tracheotomy offers several clinical benefits, including increased patient comfort, reduced sedation requirements, decreased work of breathing, improved oral hygiene, a lower risk of ventilator-associated pneumonia, and lower mortality. With the increasing use of the percutaneous technique, the procedure is increasingly performed by intensivists. Consequently, the number of patients with a tracheostomy cannula in the ICU is increasing.
Following clinical stabilisation, these patients are transferred to inpatient wards throughout the hospital according to their underlying pathology. However, nurses working on these wards encounter tracheostomy-related care less frequently, which may include suctioning, wound care, cannula care, and decannulation.
Despite the availability of clinical procedures and protocols, a lack of knowledge, skills, and confidence in providing safe tracheostomy-related care persists. This increases the risk of complications such as cannula obstruction, infection, hypoxaemia, dislodgement, and bleeding. To address this issue, specialised multidisciplinary tracheostomy teams are increasingly being implemented.
The aim of this retrospective study is to answer the following research question: What is the impact of a specialised multidisciplinary tracheostomy team on clinical outcomes in hospitalised patients with a tracheostomy cannula?
調査の概要
状態
研究の種類
入学 (推定)
連絡先と場所
研究連絡先
- 名前:Lisa Christiaens, MSc
- 電話番号:+3237606060
- メール:brecht.serraes@vitaz.be
研究場所
-
-
Oost-Vlaanderen
-
Sint-Niklaas、Oost-Vlaanderen、ベルギー、9100
- Vitaz
-
コンタクト:
- Brecht Serraes, Doctor
- 電話番号:+3237602039
- メール:brecht.serraes@vitaz.be
-
主任研究者:
- Brecht Serraes, Doctor
-
-
参加基準
適格基準
就学可能な年齢
- 子
- 大人
- 高齢者
健康ボランティアの受け入れ
サンプリング方法
調査対象母集団
説明
Inclusion Criteria:
- Hospitalisation between 2010 and 2026 in VITAZ (general hospital, Belgium)
- Age ≥18 years.
- Presence of a tracheostomy cannula (tracheotomy, permanent tracheostomy, or laryngectomy).
- Curative and palliative patients will be included.
Exclusion Criteria:
- Ambulatory care
- Day hospitalisation
研究計画
研究はどのように設計されていますか?
デザインの詳細
コホートと介入
グループ/コホート |
介入・治療 |
|---|---|
|
Pre-intervention cohort: Before specialised tracheostomy team implementation
Hospitalised patients with a tracheostomy cannula who received routine clinical care before the establishment and implementation of the specialised multidisciplinary tracheostomy team.
This cohort serves as the pre-intervention comparison group.
|
|
|
Post-intervention cohort: After specialised tracheostomy team implementation
Hospitalised patients with a tracheostomy cannula who received care after the establishment and implementation of the specialised multidisciplinary tracheostomy team.
|
The intervention of interest is the implementation of the specialised multidisciplinary tracheostomy team, which provides structured, team-based care for patients with a tracheostomy cannula.
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Tracheo(s)tomy-related ICU readmission
時間枠:through study completion, an average of 1 year
|
Occurrence of readmission to the intensive care unit due to tracheo(s)tomy cannula-related problems.
|
through study completion, an average of 1 year
|
|
Successful decannulation
時間枠:through study completion, an average of 1 year
|
Successful decannulation of the tracheo(s)tomy cannula according to predefined criteria derived from the literature.
The proportion of patients achieving successful decannulation will be compared between the pre-intervention and post-intervention cohorts.
|
through study completion, an average of 1 year
|
|
Tracheo(s)tomy-related complications
時間枠:through study completion, an average of 1 year
|
Occurrence of predefined canulla-related complications, including airway obstruction, wound infection, bleeding, ... .
|
through study completion, an average of 1 year
|
|
Performance of FEES
時間枠:through study completion, an average of 1 year
|
Performance of a fibreoptic endoscopic evaluation of swallowing (FEES) during hospitalisation.
|
through study completion, an average of 1 year
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Total hospital length of stay
時間枠:through study completion, an average of 1 year
|
From hospital admission until hospital discharge
|
through study completion, an average of 1 year
|
|
Use of high-flow oxygen therapy or active humidification
時間枠:through study completion, an average of 1 year
|
Use of high-flow oxygen therapy and/or active humidification during hospitalisation.
|
through study completion, an average of 1 year
|
|
Time to tracheo(s)tomy
時間枠:through study completion, an average of 1 year
|
Number of days from hospital admission to the performance of the tracheo(s)tomy.
|
through study completion, an average of 1 year
|
|
Time from ICU admission to transfer to an inpatient ward
時間枠:through study completion, an average of 1 year
|
Duration of intensive care unit stay before transfer to an inpatient ward.
|
through study completion, an average of 1 year
|
|
Length of ICU stay following canulla-related readmission
時間枠:through study completion, an average of 1 year
|
Duration of intensive care unit stay following readmission due to cannula-related problems.
|
through study completion, an average of 1 year
|
|
Mortality due to cannulla-related complications
時間枠:through study completion, an average of 1 year
|
Occurrence of death attributable to tracheo(s)tomy- or cannula-related complications.
|
through study completion, an average of 1 year
|
|
Use of a speaking valve
時間枠:through study completion, an average of 1 year
|
Occurrence and use of a speaking valve during hospitalisation.
|
through study completion, an average of 1 year
|
|
Responsible medical discipline
時間枠:through study completion, an average of 1 year
|
Location and discipline responsible for tracheostomy placement.
|
through study completion, an average of 1 year
|
協力者と研究者
スポンサー
出版物と役立つリンク
一般刊行物
- Ninan A, Grubb LM, Brenner MJ, Pandian V. Effectiveness of interprofessional tracheostomy teams: A systematic review. J Clin Nurs. 2023 Oct;32(19-20):6967-6986. doi: 10.1111/jocn.16815. Epub 2023 Jul 3.
- Speed L, Harding KE. Tracheostomy teams reduce total tracheostomy time and increase speaking valve use: a systematic review and meta-analysis. J Crit Care. 2013 Apr;28(2):216.e1-10. doi: 10.1016/j.jcrc.2012.05.005. Epub 2012 Aug 27.
- Parker V, Giles M, Shylan G, Austin N, Smith K, Morison J, Archer W. Tracheostomy management in acute care facilities--a matter of teamwork. J Clin Nurs. 2010 May;19(9-10):1275-83. doi: 10.1111/j.1365-2702.2009.03155.x. Epub 2010 Mar 18.
- Holmes TR, Cumming BD, Sideris AW, Lee JW, Briggs NE, Havas TE. Multidisciplinary Tracheotomy Teams: An Analysis of Patient Outcomes and Resource Allocation. Ear Nose Throat J. 2019 Apr-May;98(4):232-237. doi: 10.1177/0145561319840103. Epub 2019 Apr 2.
- Garrubba M, Turner T, Grieveson C. Multidisciplinary care for tracheostomy patients: a systematic review. Crit Care. 2009;13(6):R177. doi: 10.1186/cc8159. Epub 2009 Nov 6.
- Brenner MJ, Pandian V, Milliren CE, Graham DA, Zaga C, Morris LL, Bedwell JR, Das P, Zhu H, Lee Y Allen J, Peltz A, Chin K, Schiff BA, Randall DM, Swords C, French D, Ward E, Sweeney JM, Warrillow SJ, Arora A, Narula A, McGrath BA, Cameron TS, Roberson DW. Global Tracheostomy Collaborative: data-driven improvements in patient safety through multidisciplinary teamwork, standardisation, education, and patient partnership. Br J Anaesth. 2020 Jul;125(1):e104-e118. doi: 10.1016/j.bja.2020.04.054. Epub 2020 May 23.
研究記録日
主要日程の研究
研究開始 (推定)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
キーワード
その他の研究ID番号
- EC26004 (その他の識別子:VITAZ, commissie voor medische ethiek)
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
試験データ・資料
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。